Search details
1.
How I treat older patients with DLBCL in the frontline setting.
Blood
; 141(21): 2566-2575, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-36413153
2.
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood
; 137(5): 600-609, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33538797
3.
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.
Eur J Nucl Med Mol Imaging
; 50(2): 486-493, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36166080
4.
Cellular therapy in lymphoma.
Hematol Oncol
; 2023 Jun 29.
Article
in English
| MEDLINE | ID: mdl-37382086
5.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Lancet
; 398(10306): 1157-1169, 2021 09 25.
Article
in English
| MEDLINE | ID: mdl-34508654
6.
18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
Eur J Nucl Med Mol Imaging
; 49(3): 932-942, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34405277
7.
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
Eur J Nucl Med Mol Imaging
; 49(13): 4642-4651, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35925442
8.
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.
Dig Endosc
; 34(1): 163-170, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33928678
9.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34590303
10.
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Blood
; 133(18): 1964-1976, 2019 05 02.
Article
in English
| MEDLINE | ID: mdl-30850381
11.
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Haematologica
; 106(4): 1129-1137, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-32273476
12.
Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.
Br J Haematol
; 189(1): 117-121, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31682006
13.
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015.
Br J Haematol
; 189(6): 1093-1106, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32030738
14.
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Br J Haematol
; 190(3): 385-393, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32150297
15.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-33256379
16.
High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
Cancer
; 125(6): 990-999, 2019 03 15.
Article
in English
| MEDLINE | ID: mdl-30561773
17.
Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.
Br J Haematol
; 187(3): 347-355, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31290569
18.
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
Blood
; 129(16): 2257-2265, 2017 04 20.
Article
in English
| MEDLINE | ID: mdl-28143884
19.
Treatment of aggressive non-Hodgkin's lymphoma in frail patients: cardiac comorbidities and advanced age.
Future Oncol
; 15(11): 1197-1205, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30730219
20.
High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors.
Br J Cancer
; 118(6): 887-895, 2018 03 20.
Article
in English
| MEDLINE | ID: mdl-29381685